RTW INVESTMENTS, LP Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$593.1B
Holdings
32
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (32 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PTCTPTC Therapeutics Inc | 4,130,115 | $68.9B | 11.62% | |
| 2 | RGNXRegenxbio Inc | 1,561,210 | $51.9B | 8.75% | |
| 3 | BMYBristol-Myers Squibb Co | 839,452 | $51.4B | 8.67% | |
| 4 | ALNYAlnylam Pharmaceuticals Inc | 358,774 | $45.6B | 7.69% | |
| 5 | —Dicerna Pharmaceuticals Inc | 5,035,662 | $44.1B | 7.44% | |
| 6 | —Achillion Pharmaceuticals Inc | 13,546,902 | $39.0B | 6.58% | |
| 7 | —La Jolla Pharmaceutical Co | 1,063,170 | $34.2B | 5.77% | |
| 8 | —Avexis Inc | 281,242 | $31.1B | 5.25% | |
| 9 | I9DNArbutus Biopharma Corp | 5,151,615 | $26.0B | 4.39% | |
| 10 | GBTUSDGlobal Blood Therapeutics Inc | 601,683 | $23.7B | 3.99% | |
| 11 | EP3OraSure Technologies Inc | 878,452 | $16.6B | 2.79% | |
| 12 | BCRXBioCryst Pharmaceuticals Inc | 3,372,674 | $16.6B | 2.79% | |
| 13 | —Corium International Inc | 1,699,653 | $16.3B | 2.75% | |
| 14 | AGENEURAgenus Inc | 4,329,816 | $14.1B | 2.38% | |
| 15 | EWEdwards Lifesciences Corp | 123,000 | $13.9B | 2.34% | |
| 16 | VRAYQViewray Inc | 1,348,210 | $12.5B | 2.11% | |
| 17 | —Myokardia Inc | 257,663 | $10.8B | 1.83% | |
| 18 | 3M4Masimo Corp | 120,900 | $10.3B | 1.73% | |
| 19 | ATRAGBXAtara Biotherapeutics Inc | 556,118 | $10.1B | 1.70% | |
| 20 | —Proteostasis Therapeutics Inc | 1,500,000 | $8.7B | 1.47% | |
| 21 | —Viveve Medical Inc | 1,672,998 | $8.3B | 1.40% | |
| 22 | QUREUniqure NV | 403,524 | $7.9B | 1.33% | |
| 23 | VCELVericel Corp | 1,304,801 | $7.1B | 1.20% | |
| 24 | TCMDTactile Systems Technology Inc | 210,366 | $6.1B | 1.03% | |
| 25 | —Oxford Immunotec Global PLC | 375,792 | $5.3B | 0.89% | |
| 26 | —Bovie Medical Corp | 1,752,611 | $4.6B | 0.77% | |
| 27 | —Zynerba Pharmaceuticals Inc | 202,859 | $2.5B | 0.43% | |
| 28 | —Five Prime Therapeutics Inc | 100,377 | $2.2B | 0.37% | |
| 29 | ARGXargenx NV | 25,260 | $1.6B | 0.27% | |
| 30 | RVNCEURRevance Therapeutics Inc | 23,038 | $824.0M | 0.14% | |
| 31 | —Odonate Therapeutics Inc | 29,007 | $725.0M | 0.12% | |
| 32 | —SENSUS HEATLHCARE INC | 151,400 | $98.0M | 0.02% |